Muutke küpsiste eelistusi

Reversible Causes of Cognitive Impairment and Dementia: From Neuroscience to Clinical Practice [Pehme köide]

Edited by (Duke University Medical Center, Durham, NC), Edited by (Nassau University Medical Center, N.Y.)
  • Formaat: Paperback / softback, 348 pages, kõrgus x laius: 234x156 mm, kaal: 453 g, 18 Tables, black and white; 2 Halftones, black and white; 2 Illustrations, black and white
  • Ilmumisaeg: 12-Sep-2025
  • Kirjastus: Routledge
  • ISBN-10: 1032782935
  • ISBN-13: 9781032782935
  • Pehme köide
  • Hind: 52,74 €
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 2-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 348 pages, kõrgus x laius: 234x156 mm, kaal: 453 g, 18 Tables, black and white; 2 Halftones, black and white; 2 Illustrations, black and white
  • Ilmumisaeg: 12-Sep-2025
  • Kirjastus: Routledge
  • ISBN-10: 1032782935
  • ISBN-13: 9781032782935

This pioneering book covers a broad range of reversible causes of cognitive decline and dementia, ranging from the basic neuroscience of the condition to clinical manifestations, and practice treatment implications.



This pioneering book covers a broad range of reversible causes of cognitive decline and dementia, ranging from the basic neuroscience of the condition to clinical manifestations and practice treatment implications.

It offers something new to the field of dementia assessment and treatment by shining a light on the multiple comorbidities that compound the patient’s clinical presentation and exacerbate cognitive decline and by presenting differential diagnoses and the imperative to rule out reversible causes of cognitive impairment/dementia in one key text. Taking a global approach, chapters include mild cognitive impairment and the impact of drugs and substance abuse and other medication effects. The book goes on to look at depression and other psychiatric presentations, chronic pain, metabolic conditions, and tumors and other space-occupying lesions. Infectious diseases and other medical illnesses that affect cognition are explored, along with the impact of sleep disorders and delirium. The book concludes with a focus on applications and treatment when maximizing an older person’s functioning and assessing their cognition and/or their capacity.

It is essential reading for clinicians, researchers, and specialist nurses in aging and dementia as well as students of neuropsychology/neurocognition, medicine, and health and social work.

Arvustused

"Dr. Farrer and Dr. Schaefer have assembled a cadre of experts to bring us this go-to resource that belongs in the office of any clinician who serves older adults. Any time you suspect a treatable condition is impacting your patient's cognitive functioning, you will want to consult this book! This resource will enable clinicians to detect and treat conditions that affect cognitive functioning, and prevent mis-diagnosis of dementia."

Brian Yochim, Ph.D., ABPP, San Francisco VA Health Care System, University of California, San Francisco (UCSF), co-editor of A Handbook of Geriatric Neuropsychology: Practice Essentials and Psychology of Aging: A Biopsychosocial Perspective

"In the ever changing world of clinical diagnostics, marked by advances in biomarkers and new technologies, this book takes the clinician back to the fundamentals of differential diagnosis of cognitive disorders and does so from a contemporary scientific vantage point. The recognition of reversible causes of cognitive disorders is essential for sound clinical decision making within the practice of neuropsychology. This book is a must have resource for students of the neurosciences and for those who are entering the practice of clinical neuropsychology."

Kathleen Welsh-Bohmer, Ph.D., ABCN, Professor in Psychiatry and Behavioral Sciences & Neurology, Duke University School of Medicine & Duke Clinical Research Institute

1. Introduction: Reversible Conditions and Modifiable Risk Factors for
Dementia Lynn A. Schaefer and Thomas J. Farrer.
2. Etiology Matters:
Potential Reversibility of Mild Cognitive Impairment
Sarah E. Cote and Lisa D. Ravdin.
3. Drugs and Substance Abuse Jakob Thorn,
Doug Johnson-Greene, and Cady Block.
4. Medication Effects: The Cognitive
Impact of Drug Classes, Polypharmacy, and Drug Interactions. Eric Silk and
Dawson Hedges
5. Depression and Other Psychiatric Presentations Shawn
McClintock and Allison Gregg.
6. Persistent Pain Yana Suchy, Michelle Gereau
Mora, and Libby A. DesRuisseaux.
7. Metabolic Disorders and Reversible Causes
of Cognitive Dysfunction Margaret E. Wiggins, and Marc A. Norman.
8. Brain
Tumors Jennifer L. Nosker and Michael W. Parsons.
9. Infectious Diseases and
Dementia: Potential Interventions for Prevention and Treatment Morgan Chase
McClellan, Ethan Sage, Jonathan D. Moore, Shawn D. Gale, Dawson W. Hedges,
and Thomas J. Farrer.
10. Normal Pressure Hydrocephalus Drew M. Hodis,
Jennifer S. Shalam, Wei-Qian Wang, and Susan Farella-Busch.
11. Other Medical
Illnesses and Cognitive Impairment Eric M. Watson, Amelia J. Hicks, and
Jacqueline H. Becker.
12. The mpact of Sleep and Sleep Disorders on Cognitive
Health: Reversibility of Cognitive Impairment Associated with Sleep Disorders
Mariya Narizhnaya and Matthew R. Ebben.
13. Concepts of Multimorbidity in
Clinical Neuropsychology Jason W. Krellman and Robert Leavenworth.
14.
Delirium Kirk J. Stucky and Tracy Shannon.
15. Conclusion and Applications
Thomas J. Farrer and FLynn A. Schaefer.
Thomas J. Farrer is a board-certified clinical neuropsychologist and Assistant Professor at the University of Idaho where he serves as Associate Program Director in the School of Health and Medical Professions. He has published additional books and articles in neuropsychology and has research interests in dementia and neuroepidemiology.

Lynn A. Schaefer is a board-certified clinical neuropsychologist and Director of Neuropsychology at Nassau University Medical Center. She is a fellow of the APA and National Academy of Neuropsychology. She has published additional books and articles in neuropsychology and has interests in dementia, brain injury, educational outreach, and decision-making capacity.